1. CollPlant will present at the 27th Annual H.C. Wainwright Conference. 2. Management will participate on September 8 and 9, 2025. 3. The company specializes in rhCollagen technology for regenerative medicine. 4. CollPlant has a partnership with Allergan for dermal fillers.
Participation in major conferences typically boosts visibility and investor interest. Historical precedence shows stock rallies following such announcements, especially in biotech sectors.
The conference can lead to increased investor engagement, influencing stock performance significantly in the short term.
The event is upcoming, creating immediate investor interest and speculation on stock price movement. Quick reactions usually occur around conference dates due to potential new partnerships or announcements.
REHOVOT, Israel, Aug. 25, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ:CLGN), a regenerative and aesthetics medicine company developing disruptive technologies and products based on its non-animal-derived recombinant human collagen (rhCollagen), today announced that senior management will participate in the upcoming 27th Annual H.C. Wainwright Global Investment Conference on Monday, September 8th and Tuesday September 9th, 2025, at the Lotte New York Palace Hotel.
Investors attending the event may request a one-on-one meeting with CollPlant through their H.C. Wainwright representative or e-mail meetings@hcwco.com.
About CollPlant
CollPlant is a regenerative and aesthetic medicine company ushering in a new era of medical solutions with a focus on 3D bioprinting of tissues and organs, tissue repair and medical aesthetics. The Company's products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant-based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing.
In 2021, CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market.
For more information about CollPlant, visit http://www.collplant.com.
Contacts
CollPlant:
Eran Rotem
Deputy CEO & CFO
+972-73-2325600
Eran@collplant.com
Investors:
LifeSci Advisors
Dan Ferry
daniel@lifesciadvisors.com
Logo: https://mma.prnewswire.com/media/2217353/CollPlant_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/collplant-to-participate-in-the-upcoming-27th-annual-hc-wainwright-global-investment-conference-302537524.html
SOURCE CollPlant